{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(18)"],"submitter":["Nazzetta DC"],"pubmed_abstract":["<h4>Background</h4>Pulmonary hypertension (PH) often complicates mitral stenosis (MS). The prognostic impact of pulmonary vascular resistance (PVR) in MS patients remains unclear. Previous study has demonstrated the prognostic impact of right atrial pressure (RAP) in patients with primary PH. We aim to determine the prognostic impact of PVR and RAP in patients with rheumatic MS undergoing percutaneous mitral balloon valvuloplasty (PMBV).<h4>Methods</h4>A total of 58 patients with symptomatic severe rheumatic MS who underwent PMBV between 2016 and 2020 were included. Patients were divided into two groups: PVR ≤ 2WU (N = 26) and PVR > 2WU (N = 32). The composite endpoint included death, reintervention or persistent NYHA functional class III-IV during follow-up.<h4>Results</h4>The median age "],"journal":["Diagnostics (Basel, Switzerland)"],"pagination":["2079"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11431111"],"repository":["biostudies-literature"],"pubmed_title":["Influence of Right Atrial Pressure on the Prognosis of Patients with Rheumatic Mitral Stenosis Undergoing Percutaneous Mitral Balloon Valvuloplasty."],"pmcid":["PMC11431111"],"pubmed_authors":["de Sousa LCG","Lopes MP","Fernandes JRC","Mapa LG","Lipari LFVP","Jardim CVP","Lopes MAAM","Nazzetta DC","Campos CM","Rosa VEE","Pires LJNT","de Santis A","Tarasoutchi F","Tessari FC","Sampaio RO"],"additional_accession":[]},"is_claimable":false,"name":"Influence of Right Atrial Pressure on the Prognosis of Patients with Rheumatic Mitral Stenosis Undergoing Percutaneous Mitral Balloon Valvuloplasty.","description":"<h4>Background</h4>Pulmonary hypertension (PH) often complicates mitral stenosis (MS). The prognostic impact of pulmonary vascular resistance (PVR) in MS patients remains unclear. Previous study has demonstrated the prognostic impact of right atrial pressure (RAP) in patients with primary PH. We aim to determine the prognostic impact of PVR and RAP in patients with rheumatic MS undergoing percutaneous mitral balloon valvuloplasty (PMBV).<h4>Methods</h4>A total of 58 patients with symptomatic severe rheumatic MS who underwent PMBV between 2016 and 2020 were included. Patients were divided into two groups: PVR ≤ 2WU (N = 26) and PVR > 2WU (N = 32). The composite endpoint included death, reintervention or persistent NYHA functional class III-IV during follow-up.<h4>Results</h4>The median age ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Sep","modification":"2025-04-04T01:14:56.362Z","creation":"2025-04-04T01:14:56.362Z"},"accession":"S-EPMC11431111","cross_references":{"pubmed":["39335758"],"doi":["10.3390/diagnostics14182079"]}}